A detailed history of Core Cap Advisors, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Core Cap Advisors, LLC holds 367 shares of EW stock, worth $26,185. This represents 0.0% of its overall portfolio holdings.

Number of Shares
367
Holding current value
$26,185
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$59.7 - $93.78 $21,909 - $34,417
367 New
367 $24,000
Q1 2024

Aug 08, 2024

BUY
$72.54 - $95.56 $14,217 - $18,729
196 New
196 $18,000
Q4 2022

Feb 10, 2023

BUY
$68.3 - $87.44 $39,955 - $51,152
585 New
585 $43,000
Q2 2022

Aug 11, 2022

BUY
$86.5 - $128.27 $92,814 - $137,633
1,073 New
1,073 $102,000
Q1 2022

Apr 29, 2022

SELL
$101.96 - $128.34 $248,578 - $312,892
-2,438 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$106.37 - $130.68 $259,330 - $318,597
2,438 New
2,438 $316,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $44.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.